What it is
Regulatory status: OTC dietary supplement (US, DSHEA); food supplement (EU). Not a prescription drug. Not WADA-prohibited. A gummy is a dosage form, not a new creatine salt
At a glance
What it is, why people use it, the evidence, and what to know before trying it.
Why people use it
- Same plasma creatine exposure (Cmax / AUC) as a matched gram of monohydrate powder.
- Same muscle creatine / phosphocreatine saturation as 3–5 g/day powder.
- Same high-intensity / strength / lean-mass outcomes as powder when the daily grams match.
- Commercial gummies contain the creatine grams printed on the label.
- Creatine remains creatine (does not convert to creatinine) through manufacture and shelf life.
- The sugar / pectin matrix improves uptake versus unsweetened powder.
- “Two gummies a day” equals a research 3–5 g powder dose.
- Better adherence / convenience than powder (a use claim, not a physiology claim).
Evidence at a glance
Creatine monohydrate **as a molecule** has strong human evidence for muscle saturation and high-intensity performance — that evidence is powder, and it is in [`creatine-monohydrate.md`](creatine-monohydrate.md). A gummy that still contains **3–5 g of intact monohydrate** on the day it is eaten is **plausibly** the same intervention: Harris 2002 shows solid 2.3 g raises plasma, and Hultman 1996 shows 3 g/day for 28 days saturates muscle. That “if” is the whole review. **Commercial gummies as a class are not form-equivalent to powder.** Across NOW 2024, Smith/Eurofins 2025 and SuppCo 2025, **about half to two-thirds of tested gummies missed the label**, and a large subset had **essentially no creatine**. Even passing lots have shown **measurable creatinine**, i.e. some wet-matrix loss. The only gummy RCT (Pereira 2026, 5 g/day labelled, not two gummies) was unblinded, had no placebo and no powder arm, did not measure muscle creatine, used a brand NOW had failed, and has internal number inconsistencies. Head-to-head PK (NCT07579455) had **no results** as of 18 August 2026.